vimarsana.com

Page 280 - Initiated Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Codorus Valley Bancorp (NASDAQ:CVLY) Now Covered by StockNews com

Stock analysts at StockNews.com assumed coverage on shares of Codorus Valley Bancorp (NASDAQ:CVLY – Get Free Report) in a report released on Saturday. The brokerage set a “hold” rating on the financial services provider’s stock. Separately, Stephens reiterated an “overweight” rating and set a $22.00 price objective on shares of Codorus Valley Bancorp in a […]

Longboard Pharmaceuticals (NASDAQ:LBPH) Earns Buy Rating from Analysts at Citigroup

Citigroup began coverage on shares of Longboard Pharmaceuticals (NASDAQ:LBPH – Free Report) in a research report sent to investors on Friday, Marketbeat reports. The firm issued a buy rating and a $40.00 price target on the stock. Several other equities analysts have also recently weighed in on the company. Cantor Fitzgerald raised their price objective […]

SolarEdge Technologies (NASDAQ:SEDG) Research Coverage Started at Royal Bank of Canada

Royal Bank of Canada initiated coverage on shares of SolarEdge Technologies (NASDAQ:SEDG – Free Report) in a report published on Wednesday, MarketBeat reports. The firm issued a sector perform rating and a $85.00 target price on the semiconductor company’s stock. Other equities analysts also recently issued reports about the stock. Bank of America downgraded shares […]

Wolfe Research Begins Coverage on argenx (NASDAQ:ARGX)

Wolfe Research initiated coverage on shares of argenx (NASDAQ:ARGX – Free Report) in a research note issued to investors on Thursday, MarketBeat reports. The brokerage issued a peer perform rating on the stock. A number of other brokerages also recently commented on ARGX. TD Cowen boosted their price objective on shares of argenx from $612.00 […]

Global Cord Blood (NYSE:CO) Now Covered by Analysts at StockNews com

Stock analysts at StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO – Get Free Report) in a report released on Friday. The firm set a “strong-buy” rating on the medical research company’s stock. Global Cord Blood Trading Down 7.5 % Shares of CO opened at $1.85 on Friday. Global Cord Blood has a […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.